PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells

Oral Oncology

Volumn 45, Issue 10, 2009, Pages

  Gan, Ye Hua ^a   Zhang, Shan ^a  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

Author keywords

AKT; Apoptosis; Histone deacetylases inhibitor; Oral cancer; Oral squamous cell carcinoma; PTEN; Trichostatin A

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4',6 DIAMIDINO 2 PHENYLINDOLE; CASPASE 3; CYTOCHROME C; HISTONE DEACETYLASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SERINE; TRICHOSTATIN A;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SQUAMOUS CELL CARCINOMA; STAINING; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOCHROMES C; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; INDOLES; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; THIAZOLES; TONGUE NEOPLASMS;

EID: 70349205564     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.05.563     Document Type: Article

References (26)

1. Johnstone R.W., and Licht J.D. Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?. Cancer Cell 4 1 (2003) 13-18
2. Schmidt K., Gust R., and Jung M. Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells. Arch Pharm 332 10 (1999) 353-357
3. Butler L.M., Agus D.B., Scher H.I., et al. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res 60 18 (2000) 5165-5170
4. Herold C., Ganslmayer M., Ocker M., et al. The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. J Hepatol 36 2 (2002) 233-240
5. Donadelli M., Costanzo C., Faggioli L., et al. Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells. Mol Carcinog 38 2 (2003) 59-69
6. Duan H., Heckman C.A., and Boxer L.M. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol Cell Biol 25 5 (2005) 1608-1619
7. Kim H.R., Kim E.J., Yang S.H., et al. Trichostatin A induces apoptosis in lung cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway?. Exp Mol Med 38 6 (2006) 616-624
8. Inoue S., Riley J., Gant T.W., Dyer M.J., and Cohen G.M. Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa. Leukemia 21 8 (2007) 1773-1782
9. Melnick A., and Licht J.D. Histone deacetylases as therapeutic targets in hematologic malignancies. Curr Opin Hematol 9 4 (2002) 322-332
10. Kelly W.K., O'Connor O.A., Krug L.M., et al. Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer. J Clin Oncol 23 17 (2005) 3923-3931
11. Duvic M., and Vu J. Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma. Expert Opin Investig Drugs 16 7 (2007) 1111-1120
12. Chen C.S., Weng S.C., Tseng P.H., Lin H.P., and Chen C.S. Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes. J Biol Chem 280 46 (2005) 38879-38887
13. Sun H., Lesche R., Li D.M., et al. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA 96 11 (1999) 6199-6204
14. Dahia P.L. PTEN, a unique tumor suppressor gene. Endocr Relat Cancer 7 2 (2000) 115-129
15. Downes C.P., Bennett D., McConnachie G., et al. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN. Biochem Soc Trans 29 Pt 6 (2001) 846-851
16. Jiang B.H., and Liu L.Z. PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta 1784 1 (2008) 150-158
17. Okumura K., Mendoza M., Bachoo R.M., DePinho R.A., Cavenee W.K., and Furnari F.B. PCAF modulates PTEN activity. J Biol Chem 281 36 (2006) 26562-26568
18. Stambolic V., MacPherson D., Sas D., et al. Regulation of PTEN transcription by p53. Mol Cell 8 2 (2001) 317-325
19. Virolle T., Adamson E.D., Baron V., et al. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat Cell Biol 3 12 (2001) 1124-1128
20. Zheng J.W., Qiu W.L., and Zhang Z.Y. Combined and sequential treatment of oral and maxillofacial malignancies: an evolving concept and clinical protocol. Chin Med J (Engl) 121 19 (2008) 1945-1952
21. Liu X., and Gao Y. The role of TGF-beta on Tca83 - a tongue squamous cell carcinoma cell line. Zhonghua Kou Qiang Yi Xue Za Zhi 36 5 (2001) 376-378
22. Zhang Y., Guo C., and Yu G. A pilot study of fatty acid metabolism in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 34 1 (2005) 78-81
23. Gan Y., Wang J., Coselli J., and Wang X.L. Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells. Biochem Biophys Res Commun 365 2 (2008) 386-392
24. Georgescu M.M., Kirsch K.H., Kaloudis P., Yang H., Pavletich N.P., and Hanafusa H. Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor. Cancer Res 60 24 (2000) 7033-7038
25. Huang L., Sowa Y., Sakai T., and Pardee A.B. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites. Oncogene 19 50 (2000) 5712-5719
26. Richon V.M., Sandhoff T.W., Rifkind R.A., and Marks P.A. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci USA 97 18 (2000) 10014-10019